Published on 17 Aug 2023 on Simply Wall St. via Yahoo Finance
Key Insights
Significant insider control over Nautilus Biotechnology implies vested interests in company growth54% of the business is held by the top 6 shareholders Institutions own 22% of Nautilus Biotechnology
Every investor in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 33% to be precise, is individual insiders. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).